Displaying 49 - 60 of 85
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Immune-Mediated and Cholestatic Diseases

“Continuing the Conversation” Cholesastic Liver Disease, Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum: Meet the Experts in Cholestatic Liver Disease (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Chair’s Welcome and Introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Potential for IBAT Inhitors in PSC: Will the Paediatric Experience Translate to Adults?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IBAT Inhibitor Mechanism of Action and Experience in Paediactrics

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Role and Impact of Bile Acids in Cholestatic Liver Disease

Webcasts
View
Cirrhosis & Complications

Conclusions and future perspectives

Webcasts
View
Cirrhosis & Complications

How long, how much and to whom? Real world data from more than 5 years practice

Webcasts
View
Cirrhosis & Complications

From decompensated cirrhosis to ACLF: long term albumin among the available and novel treatments

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Q&A and Close

Webcasts
View
Displaying 49 - 60 of 85